Anzeige
Mehr »
Login
Mittwoch, 22.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
Kursexplosion von 383 % seit November und massiver Solana-Outperformer!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 908189 | ISIN: US92552V1008 | Ticker-Symbol: VS1
Tradegate
22.01.25
11:46 Uhr
11,505 Euro
+0,155
+1,37 %
Branche
Telekom
Aktienmarkt
S&P SmallCap 600
1-Jahres-Chart
VIASAT INC Chart 1 Jahr
5-Tage-Chart
VIASAT INC 5-Tage-Chart
RealtimeGeldBriefZeit
11,38511,51013:42
11,37511,51513:42
PR Newswire
121 Leser
Artikel bewerten:
(0)

Viasat, Inc.: Viasat Completes Sale of Energy Services Systems Integration Business

Finanznachrichten News

CARLSBAD, Calif., Dec. 18, 2024 /PRNewswire/ -- Viasat, Inc. (NASDAQ: VSAT), a global leader in satellite communications, today announced that it has completed the divestiture of its Energy Services System Integration (SI) business to US-based private investment firm MAG Capital Partners. No further transaction details were announced.

Gary Chase, Chief Financial Officer, Viasat said: "We are focused on taking strategic actions and continuously looking at ways to enhance our financial position and unlock value. This transaction is part of Viasat's strategy to actively manage our portfolio. While the SI business is a vibrant, stand-alone operation, it has minimal strategic synergies with our core growth businesses.

"It made strong sense for the future of the SI business - its employees and customers - to find a new owner prioritizing large-scale telecoms project work to allow the business to reach its full potential. In MAG Capital Partners, we believe we have found an owner that will help the business continue to expand. We appreciate the many contributions of our SI colleagues and wish them continued success."

SI, which was included in Viasat's acquisition of RigNet in 2021, provides engineering design, procurement services, shop assembly, factory acceptance testing, and "day 2" support for telecom systems installed on critical infrastructure projects. Approximately 80 employees currently engaged in the SI business will transfer to the new company, Nessco. The agreement includes the sale of the company's SI facility in Aberdeen, Scotland. No locations are expected to close as a result of the sale. Imperial Capital, LLC served as exclusive financial advisor to Viasat in connection with the sale of the SI business.

About Viasat
Viasat is a global communications company that believes everyone and everything in the world can be connected. With offices in 24 countries around the world, our mission shapes how consumers, businesses, governments and militaries around the world communicate and connect. Viasat is developing the ultimate global communications network to power high-quality, reliable, secure, affordable, fast connections to positively impact people's lives anywhere they are-on the ground, in the air or at sea, while building a sustainable future in space. In May 2023, Viasat completed its acquisition of Inmarsat, combining the teams, technologies and resources of the two companies to create a new global communications partner. Learn more at www.viasat.com, the Viasat News Room or follow us on Facebook, Instagram, LinkedIn, X or YouTube.

Copyright © 2024 Viasat, Inc. All rights reserved. Viasat, the Viasat logo and the Viasat Signal are registered in the U.S and in other countries to Viasat, Inc. All other product or company names mentioned are used for identification purposes only and may be trademarks of their respective owners.

Forward-Looking Statements
This press release contains forward-looking statements that are subject to the safe harbors created under the Securities Act of 1933 and the Securities Exchange Act of 1934. Forward-looking statements include, among others, statements that refer to the enhancement of financial performance and unlocking of value resulting from the active management of Viasat's portfolio; the number of employees expected to transfer to the new company; and the number of locations expected to close as a result of the sale. Readers are cautioned that actual results could differ materially from those expressed in any forward-looking statements. Factors that could cause actual results to differ include: our ability to realize the anticipated benefits of any existing or future satellite; unexpected expenses related to our satellite projects; risks associated with the construction, launch and operation of satellites, including the effect of any anomaly, launch, operational or deployment failure or degradation in satellite performance; increasing levels of competition in our target markets; our ability to successfully implement our business plan on our anticipated timeline or at all; changes in the global business environment and economic conditions; and our level of indebtedness and ability to comply with applicable debt covenants. In addition, please refer to the risk factors contained in our SEC filings available at www.sec.gov, including our most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. Readers are cautioned not to place undue reliance on any forward-looking statements, which speak only as of the date on which they are made. We undertake no obligation to update or revise any forward-looking statements for any reason.

SOURCE Viasat, Inc.

© 2024 PR Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.